NCT01042379 2026-03-13
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2 Recruiting
Clinical Trials
22 trialsNCT06647680 2026-03-06
Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）
The Affiliated Hospital of Qingdao University
Phase 2 Recruiting
NCT06130995 2026-03-05
Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
University of Oklahoma
Phase 1 Recruiting
NCT04055220 2026-02-17
REGOSTA
Centre Leon Berard
Phase NA Recruiting
NCT07353840 2026-01-20
T-START-CR
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Recruiting
NCT07328841 2026-01-09
Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy
Sun Yat-sen University
Phase 3 Recruiting
NCT07328854 2026-01-09
40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Recruiting
NCT07066189 2025-10-29
Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC
Yale University
Phase NA Recruiting
NCT07166185 2025-09-10
NEOTRAPSCAL
Blida 1 University
Recruiting
NCT06811844 2025-07-01
Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC
The First Affiliated Hospital of Xiamen University
Phase 2 Recruiting
NCT06927180 2025-06-23
SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC
Henan Cancer Hospital
Phase 2 Recruiting
NCT05416164 2025-03-26
DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy
The Netherlands Cancer Institute
Phase NA Recruiting
NCT05976815 2025-03-26
KEYMOVE
University Institute of Maia
Phase NA Recruiting
NCT04314219 2025-03-13
PTCy-PMAT
King Faisal Specialist Hospital & Research Center
Phase 3 Recruiting
NCT05918328 2025-03-07
Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC
Henan Cancer Hospital
Phase 2 Recruiting
NCT05350722 2024-12-30
ABLATIVE-2
Amsterdam UMC, location VUmc
Phase NA Recruiting
NCT06276868 2024-12-17
Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer
Henan Cancer Hospital
Phase 2 Recruiting
NCT05000697 2024-11-27
CCHOWW
Hospital Alemão Oswaldo Cruz
Phase NA Recruiting
NCT05659056 2024-04-16
Neoadjuvant Study With Pyrotinib and Trastuzumab and Abraxane in Patients With HER2-enriched Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Recruiting
NCT03125343 2023-11-07
WoW
Sahlgrenska University Hospital
Phase NA Recruiting
NCT05763992 2023-05-18
BREAKFAST-2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Recruiting
NCT04743102 2023-02-21
BIOPSY
Beijing Chao Yang Hospital
Phase NA Recruiting